Personalis, Inc. (NASDAQ
SNL) is among the 12 Best Genomics Stocks to Invest In. The Fly reported on December 2, 2025, that Morgan Stanley analyst Kallum Titchmarsh took over coverage of Personalis, Inc. (NASDAQSNL) with an Equal Weight rating and a price objective of $11, up from $9. The firm…Continue reading...